Literature DB >> 6312962

The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.

W R Osborne, C R Scott.   

Abstract

Purine nucleoside phosphorylase (NP; EC 2.4.2.1) deficiency is associated with defective T-cell and normal B-cell immunity. Biochemical mechanisms were investigated by measuring deoxyguanosine and guanosine metabolism in normal T and B lymphoblasts and NP-deficient B lymphoblasts. Deoxyguanosine kinase activity was specifically measured by using an anti-NP antibody to prevent alternative-product formation. Kinase activity towards deoxyguanosine was significantly higher in T-cells, whereas NP activity was similar in both B- and T-cells. Only in T-cells was dGTP produced from exogenous deoxyguanosine, and this was prevented by the simultaneous addition of deoxycytidine, which resulted in a concomitant increase in GTP synthesis. Inhibition by 8-aminoguanosine of NP activity in T lymphoblasts increased formation of dGTP and decreased that of GTP from deoxyguanosine and decreased the formation of GTP from guanosine. These data suggest a central role for deoxyguanosine kinase activity in the T-cell selectivity of the immune defect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312962      PMCID: PMC1152307          DOI: 10.1042/bj2140711

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity.

Authors:  T A Krenitsky; J V Tuttle; G W Koszalka; I S Chen; L M Beacham; J L Rideout; G B Elion
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

2.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  Deoxycytidine kinase. II. Purification and general properties of the calf thymus enzyme.

Authors:  J P Durham; D H Ives
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

4.  Rapid determination of nucleoside kinase and nucleotidase activities with tritium-labeled substrates.

Authors:  D H Ives; J P Durham; V S Tucker
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

5.  Studies on hypoxanthine-guanine phosphoribosyltransferase in fibroblasts from patients with the Lesch-Nyhan syndrome. Evidence for genetic heterogeneity.

Authors:  W N Kelley; J C Meade
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

6.  On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.

Authors:  D F Wentworth; R Wolfenden
Journal:  Biochemistry       Date:  1975-11-18       Impact factor: 3.162

7.  A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects.

Authors:  L H Siegenbeek Van Heukelom; J W Akkerman; G E Staal; C H De Bruyn; J W Stoop; B J Zegers; P K De Bree; S K Wadman
Journal:  Clin Chim Acta       Date:  1977-02-01       Impact factor: 3.786

8.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

9.  Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members.

Authors:  W R Osborne; S H Chen; E R Giblett; W D Biggar; A A Ammann; C R Scott
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

10.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

View more
  7 in total

1.  Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.

Authors:  F F Snyder; J P Jenuth; E R Mably; R K Mangat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

2.  A rat model of purine nucleoside phosphorylase deficiency.

Authors:  W R Osborne; R W Barton
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Nucleoside kinases in T and B lymphoblasts distinguished by autoradiography.

Authors:  W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.

Authors:  G A Kicska; L Long; H Hörig; C Fairchild; P C Tyler; R H Furneaux; V L Schramm; H L Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

5.  2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.

Authors:  Y Sidi; B S Mitchell
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts.

Authors:  B Ullman; D W Martin
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Authors:  Todd M Cooper
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.